Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Sclerosis, Relapsing-Remitting × Calcifediol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Sclerosis, Relapsing-Remitting 1 Hypocalcemia 1 Hyperparathyroidism, Secondary 1 Breast Neoplasms 1 Bone Neoplasms 1

Interventions

Vitamin D 1 Interferon beta-1b 1 Cholecalciferol 1 Calcifediol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05340985 2022-04-22

Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis

Tehran University of Medical Sciences

Phase 4 Unknown

LymphoidOther hematologic neoplasm

Multiple Sclerosis, Relapsing-Remitting, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡